|
Journal Papers, Abstracts, and Commentaries
| |
Brain large artery lymphocytic inflammation and Human
Immunodeficiency Virus-related brain arterial remodeling.
Shenoy A, Dwork A, Elkind MSV, et al
J Virol. 2018
Apr 4.
Abstract
Short-term folinic acid supplementation and aerobic exercise improve
vascular reactivity in HIV-infected individuals.
Grigoletti SS, Ribeiro JP, Sprinz E, Ribeiro PAB.
HIV
Clin Trials.
2018 Feb 5:1-4
Abstract
FULL-TEXT
ARTICLE
Central nervous system vasculitis in a patient with HIV infection: a
diagnostic challenge.
Amui NO, Silva RGF, Costa DMC, Barsottini OGP,
et al
Arq Neuropsiquiatr.
2017 Dec;75(12):897-898.
Paper
Epidemiological trends of deep venous thrombosis in HIV-infected
subjects (1997-2013): A nationwide population-based study in Spain.
Alvaro-Meca A, Ryan P, Martínez-Larrull E, et al
Eur J Intern Med.
2017 Oct 25. pii: S0953-6205(17)30420-
Abstract
The impact of dark chocolate intake on arterial
elasticity in individuals with HIV/AIDS undergoing ART: a randomized,
double-blind, crossover trial.
Teixeira AMNDC, Luzia LA, de Souza SJ, A, et al
Food Funct.
2017 May 17.
.
Abstract
Effects of pitavastatin and pravastatin on markers of immune
activation and arterial inflammation in intrepid: a randomized trial in
HIV.
Toribio M, Fitch KV, Sanchez L,
et al
AIDS.
2017 Mar 1.
Abstract
Occlusive vasculopathy in human immunodeficiency virus (HIV)-associated
vasculitis: unusual clinical and imaging course.
Ripoll E, Prieto-González S, Balagué O,
et al
Clin Exp Rheumatol. 2016 Dec 1
Abstract
Effects of Antiretroviral Therapy on Immune Function and Arterial Inflammation
in Treatment-Naive Patients With Human Immunodeficiency Virus Infection.
Zanni MV, Toribio M, Robbins GK, et al
JAMA Cardiol.
2016 Jul 1;1(4):474-80. .
Abstract
Comparative safety and efficacy of statins for primary prevention
in human immunodeficiency virus-positive patients: a systematic review and
meta-analysis.
Gili S, Grosso Marra W, D'Ascenzo F,
et al
Eur Heart J. 2016 Feb 6. pii:
ehv734.
Abstract
Vasculitis: an unusual manifestation in an HIV-infected patient.
Manuel A, Victório T, Gomes C, et al
Braz J Infect Dis. 2015 Jun 9.
Abstract
Rosuvastatin reduces vascular inflammation and T cell and
monocyte activation in HIV-infected subjects on antiretroviral therapy.
Funderburg NT, Jiang Y, Debanne SM, et al
J Acquir Immune Defic Syndr. 2014 Dec 13
Abstract
Inverse
Correlation Between Vascular Calcification and Bone Mineral Density in Human
Immunodeficiency Virus-Infected Patients.
Bellasi A, Zona S, Orlando G, Carli F
Calcif Tissue Int. 2013
Aug 23.
Abstract
Short-term folinic acid supplementation improves vascular
reactivity in HIV-infected individuals: A randomized trial.
Grigoletti SS, Guindani G, Moraes RS,
et al
Nutrition. 2013 Jun;29(6):886-91..
Abstract |
FULL-TEXT ARTICLE
Retinal Arterioles Narrow with Increasing Duration of
Anti-Retroviral Therapy in HIV Infection: A Novel Estimator of
Vascular Risk in HIV?
Pathai S, Weiss HA, Lawn SD, et al
PLoS One.
2012;7(12):e51405.
Paper
Vascular stiffness and aging in HIV.
Chan W, Dart AM.
Sex Health.
2011 Nov;8(4):474-84.
Abstract |
Arterial Stiffness Evaluation in HIV-Positive
Patients: A Multicenter Matched Control Study.
Ferraioli G, Tinelli C, Maggi P,
et al
AJR Am J Roentgenol.
2011 Nov;197(5):1258-1262..
Abstract |
Vitamin D Levels and Markers of Arterial
Dysfunction in HIV.
Shikuma C, Seto T, Liang CY, Bennett K, et al
AIDS Res Hum Retroviruses.
2011 Oct
.
Abstract
Avascular necrosis in HIV.
Mehta P, Nelson M, Brand A, Boag F.
Rheumatol Int. 2011 Sep 22
Abstract
Progressive human immunodeficiency virus-associated vasculopathy:
time to revise antiretroviral
therapy guidelines?
Ntusi NB, Taylor D, Naidoo NG, Mendelson M.
Cardiovasc J Afr.
2011 Jul-Aug;22(4):197-200.
Abstract
Immune Dysregulation and Vascular Risk in
HIV-Infected Patients: Implications for Clinical Care.
Triant VA, Grinspoon SK.
J Infect Dis.
2011 Jan 10.
Abstract |
Relationship of Body Composition, Metabolic Status,
Antiretroviral Use, and HIV Disease Factors to Endothelial Dysfunction in
HIV-Infected Subjects.
Dubé MP, Shen C, Mather KJ, et al
AIDS Res Hum Retroviruses.
2010 Aug 1
Abstract |
|
|
|
|
|
Journal Papers, Abstracts, and Commentaries
Journal Papers, Abstracts, and Commentaries
| |
Difference in Aortic Stiffness Between Treated Middle-Aged
HIV Type 1-Infected and Uninfected Individuals Largely Explained by
Traditional Cardiovascular Risk Factors, With an Additional Contribution of
Prior Advanced Immunodeficiency.
Kooij KW, Schouten J, Wit FW,
et al
J Acquir Immune Defic Syndr. 2016
Sep 1;73(1):55-62.
Abstract
Potent antiretroviral therapy for human immunodeficiency
virus infection increases aortic stiffness.
Eira M, Bensenor IM, Dorea EL,
et al
Arq Bras Cardiol. 2012 Nov 30.
Abstract
FULL-TEXT PDF ARTICLE
Rupture of a
pseudo aneurysm of the abdominal aorta in a patient with human
immunodeficiency virus infection.
Ando T, Makuuchi H, Kitanaka Y, Koizumi H.
Ann Thorac Cardiovasc Surg.
2011 Apr;17(2):198-200..
Paper |
Journal Papers, Abstracts, and Commentaries
| |
HIV-1-Associated Atherosclerosis: Unraveling the Missing Link.
Kearns A, Gordon J, Burdo TH, Qin X.
J Am Coll Cardiol.
2017 Jun 27;69(25):3084-3098.
Abstract
Brief Report: Progression of Atherosclerosis in HIV-Infected
Individuals-Prospective Data From an Asian Cohort.
Lui G, Ma RCW, Chook P, Wong CK,
et al;
J Acquir Immune Defic Syndr.
2017 Jun 1;75(2):198-202
Abstract
Rosuvastatin slows progression of subclinical
atherosclerosis in patients with treated HIV infection.
Longenecker CT, Sattar A, Gilkeson R, Mccomsey GA.
AIDS. 2016 May 19.
Abstract
Atherosclerosis is evident in treated HIV-infected subjects with low
cardiovascular risk by carotid cardiovascular magnetic resonance.
Rose KA, Vera JH, Drivas P,
et al
J Acquir Immune Defic Syndr.
2015 Nov 16
Abstract
Statin Use Is Associated With Incident Diabetes Mellitus
Among Patients in the HIV Outpatient Study.
Lichtenstein KA, Hart RL, Wood KC,
et al
J Acquir Immune Defic Syndr.
2015 Jul 1;69(3):306-311.
Abstract
Elevated Levels of Monocyte Activation Markers Are
Associated with Subclinical Atherosclerosis in HIV-Infected and
-Uninfected Men.
McKibben RA, Margolick JB, Grinspoon S, et al
J Infect Dis. 2014 Oct 30
Abstract
Can HTLV-1 Infection Be a Potential Risk Factor for
Atherosclerosis?
Layegh P, Shoeibi A, Nikkhah K, et al
Intervirology. 2014 Oct 15;57(6):365-368
Abstract
Rosuvastatin Preserves Renal Function and Lowers Cystatin
C in HIV-infected Subjects on Antiretroviral Therapy: the
SATURN-HIV Trial.
Longenecker CT, Hileman CO, Funderburg NT, McComsey GA.
Clin Infect Dis. 2014 Jul 11.
Abstract
HIV, Inflammation, and Calcium in Atherosclerosis.
Shrestha S, Irvin MR, Grunfeld C, Arnett DK.
Arterioscler Thromb Vasc Biol.
2014 Feb;34(2):244-50
Abstract
FULL-TEXT ARTICLE
Early Atherosclerosis in HIV Infected Subjects on Suppressive
Antiretroviral Treatment: Role of Osteoprotegerin.
D'Abramo A, D'Agostino C, Oliva A, et al
ISRN AIDS. 2013 Dec 5;2013:737083
Paper
HIV, Inflammation, and Calcium in Atherosclerosis.
Shrestha S, Irvin MR, Grunfeld C, Arnett DK.
Arterioscler Thromb Vasc Biol.
2013 Nov 21
Abstract
Infection duration and inflammatory imbalance are associated with
atherosclerotic risk in HIV-infected never-smokers independent of
antiretroviral therapy.
Desvarieux M, Boccara F, Meynard JL, et al
AIDS. 2013 Oct 23;27(16):2603-2614.
Abstract
FULL-TEXT PDF ARTICLE
Risk factors for subclinical atherosclerosis in HIV-infected patients
under and over 40 years: a case--control study.
Albuquerque VM, Zírpoli JC, Miranda-Filho DD,
et al
BMC
Infect Dis. 2013 Jun 18;13(1):274.
Paper |
HIV-related mechanisms in atherosclerosis and cardiovascular
diseases.
Gibellini D, Borderi M, Clň A, et al
J
Cardiovasc Med (Hagerstown). 2013 May 7.
Abstract
The effect of HIV infection on atherosclerosis and
lipoprotein metabolism: A one year prospective study.
Rose H, Low H, Dewar E, et
al
Atherosclerosis.
2013 Apr 17.
Abstract
Perturbations of circulating levels of RANKL-Osteoprotegerin Axis in Relation
to Lipids and Progression of Atherosclerosis
in HIV-Infected and -Uninfected Adults: ACTG NWCS 332/A5078 Study.
Kelesidis T, Kendall M, Yang OO, et al
AIDS Res Hum Retroviruses. 2013 Jan 25.
Abstract |
Increased Coronary
Atherosclerotic Plaque Vulnerability by Coronary Computed
Tomography Angiography in HIV-Infected Men.
Zanni MV, Abbara S, Lo J,
et al
AIDS. 2013 Jan 15.
Abstract |
Association of subclinical atherosclerosis with
lipid levels amongst antiretroviral-treated and untreated
HIV-infected women in the Women's Interagency HIV study.
Parrinello CM, Landay
AL, Hodis HN, et al
Atherosclerosis.
2012 Oct 5.
Abstract
Association of biomarkers with atherosclerosis and
risk for coronary artery disease in patients with HIV.
Falcăo MD, Zírpoli JC, Albuquerque VM,
et
al
Arq Bras Cardiol. 2012 Oct
18
Abstract
The Biology of Atherosclerosis: General Paradigms
and Distinct Pathogenic Mechanisms Among HIV-Infected Patients.
Lo J, Plutzky J.
J Infect Dis.
2012 Jun;205 Suppl 3:S368-74.
Abstract |
HIV infection and atherosclerosis : evaluating the
drivers of inflammation.
Maniar A, Ellis C, Asmuth D, et al
Eur J Prev Cardiol. 2012
May 3.
Abstract
Clinical factors and biomarkers associated with subclinical
atherosclerosis in the human immunodeficiency
virus infection.
Serrano-Villar S, Estrada V, Gómez-Garre D,
et al
Med Clin (Barc).
2012 Mar 20.
Abstract |
Effects of Lifestyle Modification and Metformin on
Atherosclerotic Indices among HIV-Infected
Patients with the Metabolic Syndrome.
Fitch K, Abbara S, Lee H,
et al
AIDS. 2011 Nov 22.
Abstract
Incipient Renal Impairment as a Predictor of Subclinical
Atherosclerosis in
HIV Infected Patients.
Serrano-Villar S, Estrada V, Gómez-Garre D,
et al
J Acquir Immune Defic Syndr.
2011 Nov 20
Abstract
Noninvasive Coronary Imaging for Atherosclerosis in
Human Immunodeficiency Virus Infection.
Gharib AM, Abd-Elmoniem KZ, Pettigrew RI, Hadigan C.
Curr Probl Diagn Radiol.
2011 November - December;40(6):262-267.
Abstract
Low plasma levels of the soluble receptor for
advanced glycation end products in HIV-infected patients
with subclinical
carotid atherosclerosis receiving combined
antiretroviral therapy.
Jeong SJ, Kim CO, Song YG,
et al
Atherosclerosis.
2011 Aug 10.
Abstract
HIV Infection and Progression of Carotid and Coronary
Atherosclerosis:
The CARE Study.
A M, Jf P, S S,
et
al
J Acquir Immune Defic Syndr.
2011 Jul 22
Abstract
Comparison of intima-media thickness and ophthalmic artery
resistance index for assessing
subclinical atherosclerosis in HIV-1-infected patients.
Grima P, Guido M, Chiavaroli R, et al
Cardiovasc Ultrasound.
2011 Apr 1;9(1):9.
Abstract
Markers of atherosclerosis and inflammation and mortality in
patients with
HIV infection.
Mangili A, Polak JF, Quach LA, et al
Atherosclerosis.
2010 Nov 17
Abstract |
Pharmacogenetics of the Metabolic Disturbances and
Atherosclerosis Associated with
Antiretroviral Therapy in HIV-Infected Patients.
Veloso S, Peraire J, Viladés C, et al
Curr Pharm Des.
2010 Aug 5
Abstract |
Micronutrient concentrations and subclinical
atherosclerosis in adults with HIV.
Falcone EL, Mangili A, Tang AM,
et al
Am J Clin Nutr. 2010 Mar 10
Abstract |
|
|
|
|
|
|
|
|
|
Journal Papers, Abstracts,
and Comment
|
| |
Utility of 2013 American College of Cardiology/American Heart Association
Cholesterol Guidelines in HIV-Infected Adults With Carotid
Atherosclerosis.
Phan BAP, Weigel B, Ma Y,
et al
Circ Cardiovasc Imaging.
2017 Jul;10(7).
Abstract
Coronary Artery Disease in HIV-Infected Patients: Downside of
Living Longer.
Lacson JC, Barnes RP, Bahrami H.
Curr Atheroscler Rep. 2017
Apr;19(4):18
Abstract
Prevalence of calcified carotid artery atheromas in panoramic
radiographs of HIV-positive patients undergoing antiretroviral treatment: a
retrospective study.
Guerreiro da Silva Júnior N, Pedreira EN, et al
Oral Surg Oral Med Oral Pathol Oral Radiol.
2014 Jan 117(1):67-74
Abstract
Rate and predictors of carotid artery intima media thickness
progression in antiretroviral-naive HIV-infected and uninfected adults: a
48-week matched prospective cohort study.
Hileman CO, Carman TL, Longenecker CT,
et al
Antivir Ther. 2013 Jun 11.
.
Abstract |
|
Journal Papers, Abstracts, and
Commentaries
| |
Idiopathic intracranial hypertension associated with anaemia,
secondary to antiretroviral drug in a human immunodeficiency virus positive
patient
Ananth JV, Sudharshan S, Selvakumar A,
et al
Indian J Ophthalmol.
2018 Jan;66(1):168-169.
Abstract
Risk of intracerebral hemorrhage in
HIV/AIDS: a systematic review and meta-analysis.
Behrouz R, Topel CH, Seifi A,
et al
J Neurovirol. 2016 Apr 4.
Abstract
Human Immunodeficiency Virus-Associated Cerebral Aneurysmal
Vasculopathy: A Systematic Review.
Baeesa SS, Bakhaidar M, Almekhlafi MA, Madani TA.
World Neurosurg.
2015 Nov 23.
Abstract
Cerebrovascular events in HIV-infected
patients: An analysis of a cohort of 3203 HIV+ patients
during the times of cART.
Arentzen M, Jubt F, Evers S, et al
Int J Neurosci. 2014
Aug 26:1-22
Abstract
Incidence and clinical features of
cerebrovascular disease among HIV-infected adults in
the Southeastern United States.
Vinikoor MJ,
Napravnik S, Floris-Moore M,
et
al
AIDS Res Hum Retroviruses.
2013 Apr 9.
Abstract
Association between ALT level and the rate of
cardio/cerebrovascular events in HIV-positive individuals:
The D: A: D Study.
Sabin CA, Ryom L, Kovari H, et al
J Acquir Immune Defic Syndr.
Abstract |
Cerebrovascular
disease in HIV-infected individuals in the
era of highly active antiretroviral therapy.
Cruse B, Cysique LA, Markus R, Brew BJ.
J Neurovirol.
2012 Apr 14.
Abstract |
|
Journal Papers, Abstracts, and Commentaries
|
HIV
Cardiovascular Main Page
